Health & Lifestyle

eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 
eg: UK or Brides UK or Classical Art or Buy Music or Spirituality
 
Business & Money
Technology
Women
Health
Education
Family
Travel
Cars
Entertainment
SD Editorials
Online Guide and article directory site.
Foodeditorials.com
Over 15,000 recipes & editorials on food.
Lyricadvisor.com
Get 100,000 Lyric & Albums.

Video on Obesity Treatment Medication Acomplia Rimonabant

    View: 
Similar Videos
Videos on Acomplia Launch Gave Respite to Obese
Videos on Acomplia: Defeat the Fat
Videos on Acomplia: An Appetite Suppressant or a Rescuer Decide After Use
Videos on Acomplia diet tablet: Way out of obesity
Videos on Acomplia: The Fat Reducer and Obesity Remover
Videos on Acomplia Diet Pill: Managing Obesity Effectually
Videos on Acomplia Drug, Rimonabant the Active Force
Videos on Acomplia (Rimonabant) Diet Drug: Wiping Out Obesity
Videos on orAcomplia: Taming obesity
Videos on Acomplia Pill: Slimming Made Unproblematic
Videos on Generic Acomplia Rimonabant Zimulti available in Market now
Videos on Acomplia Rimonabant for Obesity Treatment
Videos on Bask paragon fitness with Acomplia
Videos on Overweight: Get fantastic results by using acomplia
Videos on Buy Acomplia | Cheap Acomplia | Online Soma | Cheap Soma
Videos on Online Pharmacy | Online Soma | Cheap Acomplia
Videos on Generic Acomplia Rimonabant Drug Information
Videos on Acomplia Diet Pill for drive obesity towards Slimness
Videos on Truth About Acomplia Rimonabant Diet Pills
Videos on Acomplia: Ups and Downs
 
Obesity Treatment Medication Acomplia Rimonabant
Katie E Lynn
Pharmaceutical company Sanofi Aventis manufactures rimonabant. It is generic name of the branded medication Acomplia. It is an obesity treatment medication.
What is obesity?
Obesity is a serious condition wherein a person has more weight than is healthy. Obesity leads to various diseases that may prove to be fatal, if timely action is not taken. Some of the diseases caused by obesity are diabetes, high blood pressure, and even cancer.
Many countries are facing more and more hospital cases because of obesity; financial losses are also mounting because of the condition. Cases of morbid obesity are also rising and this condition is highly fatal. In order to avoid obesity turning into morbid obesity, it is very important that you take steps to lose weight.
You should first try to lose weight with conventional methods such as dieting and exercising. If however, you do not lose weight with the help of these methods, you can consult a doctor and ask him to suggest some weight loss aids.
Causes of obesity
Obesity can be caused by genetic factors, hormonal problems and lifestyle factors. Sometimes environmental factors also play a big role in obesity. If your family members and relatives are obese then your obesity is caused by genetic factors. If you lead a sedentary lifestyle, do not exercise much and eat a lot of junk food then you stand a high chance of becoming obese.
Whether your obesity is caused by lifestyle or environmental or any factors, it is important to fight it. Ask a doctor if you can take Acomplia or any other obesity medication.
Obesity medication Acomplia
Acomplia was approved for use in obese patient on 28th June 2006 in the UK. The active ingredient in Acomplia is rimonabant. It is a prescription drug for obesity.
Acomplia is an obesity treatment for obese patients with a BMI of 30 and above. It can also be taken by overweight patients with other risk factors such as type 2 diabetes or dyslipidaemia. Acomplia reduces the risk of obesity related diseases such as heart disease and diabetes. Although Acomplia is an obesity drug, it is also beneficial for smoking cessation. However, this benefit of Acomplia is not yet approved for use.
Acomplia has been shown to have beneficial effect on blood glucose and fat levels. Moreover, it raises HDL cholesterol levels (good cholesterol).
Acomplia clinical trials
Following are the results of Acomplia clinical trials:
  • 33% patients who were given Acomplia in clinical trials lost more than 10% of their original body weight
  • 67% patients on Acomplia lost more than 5% of their initial body weight
  • Patients on placebo and calorie-controlled diet lost significantly lower weight compared to those on Acomplia
  • Patients who took Acomplia for more than a year did not regain weight
  • Ingredients, strength, side effects of Acomplia
    The active ingredient in Acomplia is rimonabant, which is a CB-1 receptor antagonist. Acomplia works as an appetite suppressant. You can get Acomplia in 10mg and 20mg dosage strengths. Never take Acomplia for cosmetic purposes, it is a prescription medication and should be taken under a doctor's guidance only.
    Acomplia has few side effects such as nausea, dizziness, diarrhoea, vomiting, hypoglycaemia, anxiety, and mood swings. Most side effects of Acomplia are temporary in nature and go away as your body adjusts to the medication. Acomplia side effects are also transient and reversible in nature and disappear when you stop the treatment.
    Next Paragraph..
    A Guide to Business | Guide to Technology | Guide to Women | Guide to Health | Family Guide to | Travel & Vacations | Information on Cars

    EditorialToday Health & Lifestyle has 7 sub sections. Such as Supplements Guide, Guide to Vitamins, Health Conditions, Tips on health, Healthy Lifestyle, Body Cleansing and Sexual Health. With over 20,000 authors and writers, we are a well known online resource and editorial services site in United Kingdom, Canada & America . Here, we cover all the major topics from self help guide to A Guide to Business, Guide to Finance, Ideas for Marketing, Legal Guide, Lettre De Motivation, Guide to Insurance, Guide to Health, Guide to Medical, Military Service, Guide to Women, Pet Guide, Politics and Policy , Guide to Technology, The Travel Guide, Information on Cars, Entertainment Guide, Family Guide to, Hobbies and Interests, Quality Home Improvement, Arts & Humanities and many more.
    About Editorial Today | Contact Us | Terms of Use | Submit an Article | Our Authors